Preserved postischemic heart function in sucrose-fed type 2 diabetic OLETF rats

被引:17
作者
Chen, H
Higashino, H
Kamenov, ZA
Azuma, M
Lee, WH
Yang, XQ
Zhou, DJ
Yuan, WJ
机构
[1] Second Mil Med Univ, Dept Pharmacol, Shanghai 200433, Peoples R China
[2] Kinki Univ, Sch Med, Dept Pharmacol, Osaka 5898511, Japan
[3] Alexandrov Hosp, High Med Sch, Clin Endocrinol, Sofia 1431, Bulgaria
关键词
hyperglycemia; type; 2; diabetes; ischemia and reperfusion; heart function; norepinephrine;
D O I
10.1016/S0024-3205(03)00189-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cardiovascular disease is one of the most important causes of morbidity and mortality in diabetes mellitus, but there has been controversy over functional impairment of diabetic hearts and their tolerance to ischemia. We studied ischemic heart function in type 2 diabetic rats with different degrees of hyperglycemia and its relationship with cardiac norepinephrine release. Otsuka Long-Evans Tokushima Fatty rats (OLETF) and age-matched Long-Evans Tokushima Otsuka normal rats (LETO) were used. One group of OLETF rats was given 30% sucrose in drinking water (OLETF-S). Hearts were isolated and perfused in a working heart preparation and subjected to 30 min ischemia followed by 40 min reperfusion at age of 12 months. Hemodynamics and coronary norepinephrine overflow were examined. Fasting plasma glucose in OLETF increased markedly at 12 months and sucrose administration exacerbated hyperglycemia in diabetic rats (LETO 6.6 +/- 0.5, OLETF 8.3 +/- 0.7, OLETF-S 15.0 +/- 1.7 mmol/L, P < 0.01). Basic cardiac output in OLETF was decreased as compared with LETO and OLETF-S (LETO 29.4 +/- 2.5, OLETF 24.0 +/- 2.4, OLETF-S 27.0 +/- 0.9 ml/min/g, P < 0.05) and remained very low after ischemia, while in OLETF-S it was well preserved (OLETF 4.2 +/- 2.1, OLETF-S 13.7 +/- 2.6 ml/min/g, P < 0.01). Correspondently, cardiac norepinephrine released during ischemia and reperfusion was lower in OLETF-S (OLETF 2.3 +/- 1.0, OLETF-S 0.7 +/- 0.1 pmol/ml, P < 0:01). Thus, OLETF hearts were more vulnerable to ischemia but sucrose feeding rendered their hearts resistant to ischemia. Less norepinephrine release may play a role in preventing postischemic functional deterioration in sucrose.-fed diabetic hearts. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:2839 / 2851
页数:13
相关论文
共 36 条
  • [21] Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM patient outcomes research team
    Meigs, JB
    Singer, DE
    Sullivan, LM
    Dukes, KA
    DAgostino, RB
    Nathan, DM
    Wagner, EH
    Kaplan, SH
    Greenfield, S
    [J]. AMERICAN JOURNAL OF MEDICINE, 1997, 102 (01) : 38 - 47
  • [22] DEVELOPMENT AND CHARACTERISTICS OF A NEW STRAIN OF OBESE HYPERINSULINEMIC AND HYPERLIPIDEMIC DAHL SALT-SENSITIVE RAT - THE DAHL SALT-SENSITIVE/NIH-CORPULENT RAT
    MICHAELIS, OE
    VELASQUEZ, MT
    ABRAHAM, AA
    SERVETNICK, DA
    SCHOLFIELD, DJ
    HANSEN, CT
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (05) : 467 - 473
  • [23] Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model
    Mizushige, K
    Yao, L
    Noma, T
    Kiyomoto, H
    Yu, Y
    Hosomi, N
    Ohmori, K
    Matsuo, H
    [J]. CIRCULATION, 2000, 101 (08) : 899 - 907
  • [24] Protein kinase C inhibitors abolish the increased resistance of diabetic rat heart to ischemia-reperfusion injury
    Moon, CH
    Jung, YS
    Lee, SH
    Baik, EJ
    [J]. JAPANESE JOURNAL OF PHYSIOLOGY, 1999, 49 (05) : 409 - 415
  • [25] NAKAI T, 1990, MED TECH, V18, P365
  • [26] NelissenVrancken HJMG, 1996, CIRCULATION, V93, P349
  • [27] PYORALA K, 1987, Diabetes Metabolism Reviews, V3, P463
  • [28] Protection of ischemic hearts by high glucose is mediated, in part, by GLUT-4
    Ramasamy, R
    Hwang, YYC
    Whang, J
    Bergmann, SR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (01): : H290 - H297
  • [29] Ravingerova T., 1996, Diabetes Research and Clinical Practice, V31, pS105, DOI 10.1016/0168-8227(96)01237-5
  • [30] Remme WJ, 1998, EUR HEART J, V19, pF62